Efficacy and Safety of Atogepant for Preventing Chronic and Episodic Migraines: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Current Treatment Options in Neurology · 2024-09 · 26 (9) · 411-419
DOI: 10.1007/s11940-024-00803-9 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Current Treatment Options in Neurology, online erschienen am 12.07.2024. Verfasst von Lucca Moreira Lopes und 8 weiteren Autor:innen. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 23 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Lopes, L. M., Almeida, A. M. D., Pasqualotto, E., Sudo, R. Y. U., Leite, M. G. H. S. J., Souza, M. E. C., Moraes, F. C. A. D., Siebel, V. M., & Figueiredo, N. (2024). Efficacy and Safety of Atogepant for Preventing Chronic and Episodic Migraines: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Current Treatment Options in Neurology, 26(9), 411-419. https://doi.org/10.1007/s11940-024-00803-9
Vancouver
Lopes LM, Almeida AMD, Pasqualotto E, Sudo RYU, Leite MGHSJ, Souza MEC, et al. Efficacy and Safety of Atogepant for Preventing Chronic and Episodic Migraines: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Current Treatment Options in Neurology. 2024;26(9):411-419. doi:10.1007/s11940-024-00803-9
BibTeX
@article{Lopes2024,
author = {Lopes, Lucca Moreira and Almeida, Artur Menegaz de and Pasqualotto, Eric and Sudo, Renan Yuji Ura and Leite, Marianna Gerardo Hidalgo Santos Jor and Souza, Maria Eduarda Cavalcanti and Moraes, Francisco Cezar Aquino de and Siebel, Victória Morbach and Figueiredo, Nathália},
title = {Efficacy and Safety of Atogepant for Preventing Chronic and Episodic Migraines: A Systematic Review and Meta-Analysis of Randomized Controlled Trials},
journal = {Current Treatment Options in Neurology},
year = {2024},
volume = {26},
number = {9},
pages = {411--419},
doi = {10.1007/s11940-024-00803-9}
}
EUVIMED